UBS Group’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.7M | Buy |
412,015
+200,415
| +95% | +$11.5M | ﹤0.01% | 1716 |
|
|
2025
Q1 | $12.3M | Buy |
211,600
+57,487
| +37% | +$3.35M | ﹤0.01% | 2182 |
|
|
2024
Q4 | $12.4M | Buy |
154,113
+62,619
| +68% | +$5.04M | ﹤0.01% | 2157 |
|
|
2024
Q3 | $7.33M | Buy |
91,494
+21,899
| +31% | +$1.75M | ﹤0.01% | 1936 |
|
|
2024
Q2 | $4.25M | Buy |
69,595
+16,749
| +32% | +$1.02M | ﹤0.01% | 2255 |
|
|
2024
Q1 | $2.61M | Buy |
52,846
+20,205
| +62% | +$999K | ﹤0.01% | 2745 |
|
|
2023
Q4 | $1.37M | Buy |
32,641
+29,205
| +850% | +$1.22M | ﹤0.01% | 3189 |
|
|
2023
Q3 | $113K | Sell |
3,436
-15,547
| -82% | -$510K | ﹤0.01% | 4647 |
|
|
2023
Q2 | $671K | Sell |
18,983
-33,634
| -64% | -$1.19M | ﹤0.01% | 3590 |
|
|
2023
Q1 | $1.49M | Buy |
52,617
+45,605
| +650% | +$1.3M | ﹤0.01% | 2845 |
|
|
2022
Q4 | $291K | Buy |
7,012
+5,189
| +285% | +$216K | ﹤0.01% | 4101 |
|
|
2022
Q3 | $75K | Buy |
1,823
+1,023
| +128% | +$42.1K | ﹤0.01% | 4911 |
|
|
2022
Q2 | $26K | Sell |
800
-19,706
| -96% | -$640K | ﹤0.01% | 5530 |
|
|
2022
Q1 | $718K | Buy |
20,506
+1,837
| +10% | +$64.3K | ﹤0.01% | 3515 |
|
|
2021
Q4 | $467K | Buy |
18,669
+18,052
| +2,926% | +$452K | ﹤0.01% | 4034 |
|
|
2021
Q3 | $24K | Buy |
+617
| New | +$24K | ﹤0.01% | 5843 |
|